These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11787373)

  • 1. [Can we modify colonic microflora and to what end?].
    Bouhnik Y
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C101-4. PubMed ID: 11787373
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?
    Howarth GS
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1777-9. PubMed ID: 19120868
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.
    Amit-Romach E; Uni Z; Reifen R
    Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Probiotics. A review].
    Giorgi PL
    Recenti Prog Med; 2009 Jan; 100(1):40-7. PubMed ID: 19445282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics and acute pancreatitis: there is still a long way to go!
    Uomo G
    JOP; 2008 May; 9(3):362-4. PubMed ID: 18469456
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial.
    Lin HC; Hsu CH; Chen HL; Chung MY; Hsu JF; Lien RI; Tsao LY; Chen CH; Su BH
    Pediatrics; 2008 Oct; 122(4):693-700. PubMed ID: 18829790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing necrotizing enterocolitis: what works and how safe?
    Bell EF
    Pediatrics; 2005 Jan; 115(1):173-4. PubMed ID: 15629996
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.
    Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH
    Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and intestinal inflammatory disorders in infants and children.
    Vanderhoof JA
    J Pediatr Gastroenterol Nutr; 2000; 30 Suppl 2():S34-8. PubMed ID: 10749399
    [No Abstract]   [Full Text] [Related]  

  • 13. Profiling of composition and metabolic activities of the colonic microflora of growing pigs fed diets supplemented with prebiotic oligosaccharides.
    Mountzouris KC; Balaskas C; Fava F; Tuohy KM; Gibson GR; Fegeros K
    Anaerobe; 2006 Aug; 12(4):178-85. PubMed ID: 16731014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Probiotics: history, definition, requirements and possible therapeutic applications].
    Montalto M; Arancio F; Izzi D; Cuoco L; Curigliano V; Manna R; Gasbarrini G
    Ann Ital Med Int; 2002; 17(3):157-65. PubMed ID: 12402663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral probiotics prevent necrotizing enterocolitis.
    Stricker T; Braegger CP
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):446-7. PubMed ID: 16641587
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection from gastrointestinal diseases with the use of probiotics.
    Marteau PR; de Vrese M; Cellier CJ; Schrezenmeir J
    Am J Clin Nutr; 2001 Feb; 73(2 Suppl):430S-436S. PubMed ID: 11157353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metchnikoff and the centenary of probiotics: an update of their use in gastroenteric pathology during the age of development.
    Caramia G
    Minerva Pediatr; 2008 Dec; 60(6):1417-35. PubMed ID: 18971903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pouchitis, chronic inflammatory bowel diseases, irritable colon. To prevent with a bacteria-cocktail?].
    MMW Fortschr Med; 2003 Nov; 145(46):49. PubMed ID: 14699836
    [No Abstract]   [Full Text] [Related]  

  • 20. Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract.
    Daniluk U; Alifier M; Kaczmarski M
    Adv Med Sci; 2012; 57(2):175-82. PubMed ID: 22968339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.